Cargando…
Immunotherapy For Ovarian Cancer: Recent Advances And Combination Therapeutic Approaches
Epithelial ovarian cancer (EOC) is the most lethal gynaecological cancer. Although many advances have been made in therapeutic strategies, the global standard of care still remains radical surgery plus chemotherapy, but new scenarios need to be explored to improve survival. The role of immunotherapy...
Autores principales: | Palaia, Innocenza, Tomao, Federica, Sassu, Carolina Maria, Musacchio, Lucia, Benedetti Panici, Pierluigi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326187/ https://www.ncbi.nlm.nih.gov/pubmed/32617007 http://dx.doi.org/10.2147/OTT.S205950 |
Ejemplares similares
-
Ovarian Cancer Metastasis to the Breast: A Case Report and Review of the Literature
por: Caruso, Giuseppe, et al.
Publicado: (2020) -
First-Line Treatment with Olaparib for Early Stage BRCA-Positive Ovarian Cancer: May It Be Possible? Hypothesis Potentially Generating a Line of Research
por: Tomao, Federica, et al.
Publicado: (2020) -
Systematic lymph node dissection during interval debulking surgery for advanced epithelial ovarian cancer: a systematic review and meta-analysis
por: Caruso, Giuseppe, et al.
Publicado: (2022) -
Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors
por: De Felice, Francesca, et al.
Publicado: (2015) -
Recurrent mantle cell lymphoma in the uterine cervix: a case report
por: Santangelo, Giusi, et al.
Publicado: (2020)